Part I: Esophageal Cancer.- Chapter 1. Proximal/Cervical Esophageal Cancer.- Chapter 2. Mid/Distal Esophageal Cancer and Gastroesophageal Junction Cancer.- Part II: Stomach Cancer.- Part III: Hepatobiliary Malignancies.- Chapter 5. Extrahepatic Cholangiocarcinoma and Gall Bladder Cancer.- Chapter 6. Non-Colorectal Liver Metastases.- Chapter 7. Proton Therapy.- Part IV: Pancreatic Cancer.- Chapter 8. Resectable and Borderline Resectable Pancreatic Cancer.- Chapter 9. Locally-Advanced Pancreatic Cancer.- Part V: Colorectal Cancer.- Chapter 11. Rectal Cancer.- Chapter 12. Colorectal Liver Metastases.- Part VI: Anal Cancer. - Chapter 13. Carcinoma of the Anal Canal.- Part VII. General Considerations.- Chapter 14. Dosimetry and Physics Quality Assurance
Dr. Suzanne M. Russo is an Associate Professor at Case Western Reserve University School of Medicine, Cleveland, Ohio, USA. Her research and clinical interests include the multidisciplinary treatment of cancers of the esophagus, stomach, liver, pancreas, bile duct, rectum, colon, and anus, as well as drug–radiation interactions and application of technology in cancer treatment. Dr. Russo is experienced with a wide range of advanced radiation therapy techniques. She is a member of the ECOG-ACRIN Gastrointestinal Committee and the American College of Radiology Appropriateness Criteria Expert Panel for Rectal Cancer. Dr. Russo has been principal investigator/co-investigator in multiple investigator-initiated clinical trials studying drug–radiation interactions in patients with gastrointestinal malignancies and has served as institutional investigator for cooperative group trials dedicated to finding more effective treatments for these malignancies. She has published over 65 peer-reviewed papers as well as numerous textbook chapters and is an editorial board member and reviewer for various oncology journals.
Dr. Sarah Hoffe is the Section Head of GI Radiation
Oncology at Moffitt Cancer Center, Tampa, Florida, USA, and an
Associate Member at Moffitt, as well as Associate Professor in the
University of South Florida Morsani College Of Medicine’s
Department of Oncologic Sciences. Her research and clinical
interests include cancers of the esophagus, stomach, liver,
pancreas, bile duct, rectum, colon, and anus, as well as
neuroendocrine cancers. Dr. Hoffe has experience with diverse
advanced radiation therapy techniques. At Moffitt, she works
closely with her multidisciplinary colleagues in GI surgery,
medical oncology, gastroenterology, radiology, and pathology to
develop new treatments for patients with GI cancers. She is the
past Director of eContouring at ASTRO. She is on the advisory board
for the journals Contemporary Radiation Oncology and the
editorial board of Cancer Control. She is a member of the GI
ASCO program committee and is Moffitt Cancer Center’s
representative on the NCCN panel on Cancers of the Colon, Rectum,
and Anus. She has authored over 90 publications in peer-reviewed
journals.
Dr. Edward Kim is an Associate Professor and disease site lead for gastrointestinal cancers in the Department of Radiation Oncology, University of Washington, USA. He specializes in the treatment of gastrointestinal cancers and is experienced with intensity-modulated radiation therapy (IMRT), three-dimensional conformal radiation therapy (3D-CRT), brachytherapy, proton radiotherapy, neutron therapy, stereotactic body radiation therapy (SBRT), image-guided radiation therapy (IGRT), and intraoperative radiotherapy. He chairs the Radiological Society of North America Radiation Oncology Scientific Program Committee and is the author of numerous publications in peer-reviewed journals and textbooks.
“The book covers sites from the oesophagus to the anus providing treatment algorithms and detailed assessment of treatment modalities. While the text focuses on radiation therapy techniques it incorporates information on combination with systemic agents, surgery and ablative therapy. … This book is an ideal practical reference text for clinicial/radiation oncologists with an interest in gastrointestinal malignancies.” (RAD Magazine , December, 2018)
|
Ask a Question About this Product More... |
|
